Marsi bionics
Developing disruptive innovative therapies to the healthcare sector.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- woman founder
- spinout
- eit ecosystem
- eit health
- direct-to-consumer
- eit supernovas
- tech for hospitals and clinics
- rehabilitation
- physician support tools
- disability tech
- chronic disease
- medical robots
- innovation procurements
- european health catapult (eit health)
- treatment assistance
- exoskeleton
- european health catapult 2016 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
* | €4.5m | Early VC | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 1130 % | 108 % | (16 %) | (44 %) | 582 % | 11 % | 26 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (184 %) | (148 %) | 157 % | (814 %) | (255 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 7 % | (133 %) | 149 % | (810 %) | (87 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Marsi Bionics is a pioneering company based in Madrid, Spain, specializing in the development of robotic exoskeletons. These exoskeletons are wearable devices designed to assist individuals with mobility impairments, particularly children. The company's flagship product, the Atlas Pediatric Exo, is specifically tailored for pediatric patients, helping them to walk and improve their quality of life.
Marsi Bionics operates in the healthcare and medical devices market, focusing on innovative solutions for rehabilitation and mobility. Their primary clients include hospitals, rehabilitation centers, and families of children with mobility challenges. By targeting this niche market, Marsi Bionics addresses a significant need for advanced rehabilitation technologies.
The business model of Marsi Bionics is centered around the design, manufacturing, and sale of their exoskeleton products. They generate revenue through direct sales of these devices to healthcare institutions and private clients. Additionally, they may engage in partnerships and collaborations with medical research institutions to further enhance their product offerings and expand their market reach.
Marsi Bionics stands out due to its commitment to innovation and its focus on pediatric care. The company leverages cutting-edge technology and extensive research to develop products that not only assist with mobility but also contribute to the overall well-being of their users. By addressing a critical gap in the market, Marsi Bionics is well-positioned for growth and continued success.
Keywords: robotic exoskeletons, pediatric care, mobility assistance, rehabilitation, healthcare innovation, medical devices, Atlas Pediatric Exo, hospitals, rehabilitation centers, Spain.